Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ElevateBio logo — A cell and gene therapy company accelerating access to techn...

ElevateBio

A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.

Founded 2021 United States Waltham, United States 494 employees Series D Total: $1.25B Biotechnology

General Information

Company Name ElevateBio
Founded Year 2021
Location United States Waltham, United States
Employees 494
Industries Biotechnology
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with ElevateBio. To contact ElevateBio, visit elevate.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ElevateBio compare?

A PDF of ElevateBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ElevateBio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ElevateBio

ElevateBio is a biotechnology startup that aims to revolutionize medicine by accelerating access to cutting-edge cell and gene therapy technologies. The company, founded in 2021 and headquartered in the United States, has quickly gained attention in the industry. ElevateBio boasts a robust team of industry-leading talent and has established state-of-the-art facilities to drive the development and commercialization of transformative therapies. Its integrated technology platforms, including gene editing and induced pluripotent stem cells, are paving the way for innovative medical solutions. ElevateBio's groundbreaking BaseCamp is a purpose-built manufacturing platform that offers process innovation and Good Manufacturing Practice capabilities, enabling the production of viral vectors, RNA, and cell therapies. The recently secured $14.00M in Angel Round investment on 23 March 2021 from Qiming Venture Partners speaks to the confidence that industry insiders have in the company's potential. ElevateBio is rapidly expanding its collaborations with industry partners and selectively developing its portfolio of cellular and genetic medicines. With its team of forward-thinking scientists and drug developers, ElevateBio is blurring the boundaries between technology and healthcare, redefining the notion of a technology company in drug development. Their efforts are poised to make a profound impact on the future of medicine.

Business keywords: cell and gene therapy, technology-driven company, innovation, commercialization, gene editing, induced pluripotent stem cells (iPSCs), protein engineering, vector engineering, cellular engineering, manufacturing platform, process innovation, drug development, collaborations

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $401.00M 18
EDBI Emerson Collective Invus
EDBI, Emerson Collective +16
01 May 2023
Series C $525.00M 10
EDBI Emerson Collective Invus
EDBI, Emerson Collective +8
01 Mar 2021
Series B $170.00M 9
EDBI Invus Redmile Group
EDBI, Invus +7
01 Mar 2020
Series A $150.00M 5
Redmile Group EcoR1 Capital F2 Ventures
Redmile Group, EcoR1 Capital +3
01 Jun 2019
Series A Undisclosed -
01 Jan 2018

ElevateBio Alternatives & Competitors

View All Alternatives
ElevateBio vs
RoslinCT
RoslinCT United Kingdom

Your Advanced Cell & Gene Therapy CDMO Partner

Private Equity
350 employees
Biotechnology, Manufacturing
Compare ElevateBio vs RoslinCT
ElevateBio vs
ProBio
ProBio United States

Manufacturing Life-Changing Therapies

Series C
246 employees
Biopharma, Biotechnology
ElevateBio vs
iCamuno Biotherapeutics Pty Ltd
iCamuno Biotherapeutics Pty Ltd China

iCamuno starts with induced pluripotent stem cells (iPSCs) and uses cutting-edge technologies such a...

Series A
5 employees
Biopharma, Biotechnology
View all alternatives

FAQ About ElevateBio

A cell and gene therapy company accelerating access to technologies and expertise to change the future of medicine.
ElevateBio was founded in 2021.
ElevateBio is headquartered in Waltham, United States.
ElevateBio operates in Biotechnology. Its work centres on cell and gene therapy, technology-driven company, innovation and commercialization.
ElevateBio has approximately 494 employees.
ElevateBio has completed 5 funding rounds, raising a total of $1.25B. The latest funding stage is Series D.
Top alternatives and competitors to ElevateBio include RoslinCT, ProBio, iCamuno Biotherapeutics Pty Ltd, Porton Advanced | ATMP CDMO/CRO, WuXi Advanced Therapies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ElevateBio and RoslinCT are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ElevateBio, https://bouncewatch.com/company/elevatebio, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout